"The book is designed to be accessible to readers with an intermediate knowledge of statistics, and can be a useful resource to statisticians, medical researchers, and regulatory personnel in drug development, as well as graduate students in the health sciences. The authors' dec…
"27" Result
Sort By:
With the critical role of statistics in the design, conduct, analysis and reporting of clinical trials or observational studies intended for regulatory purposes, numerous guidelines have been issued by regulatory authorities around the world focusing on statistical issues relate…
"The book is designed to be accessible to readers with an intermediate knowledge of statistics, and can be a useful resource to statisticians, medical researchers, and regulatory personnel in drug development, as well as graduate students in the health sciences. The authors' dec…
With the critical role of statistics in the design, conduct, analysis and reporting of clinical trials or observational studies intended for regulatory purposes, numerous guidelines have been issued by regulatory authorities around the world focusing on statistical issues relate…
Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to…
"Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to 5,175 dollars. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and…
""Adverse Events" explores the connections between race, inequality, and the testing of new pharmaceuticals"--
""Adverse Events" explores the connections between race, inequality, and the testing of new pharmaceuticals"-- "Imagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must sp…
Safe and effective medicines for children: studies conducted under the Best Pharmaceuticals …
by Institute of Medicine (États-Unis)., Board on Health Sciences Policy, Field, Marilyn J., (Marilyn Jane), Boat, Thomas F., Institute of Medicine (U.S.)., Committee on Pediatric Studies Conducted under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equality Act (PREA)
0
Type: Book
"The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted…
Safe and effective medicines for children: studies conducted under the Best Pharmaceuticals …
by Institute of Medicine (U.S.)., Board on Health Sciences Policy, Field, Marilyn J., (Marilyn Jane), Boat, Thomas F., Institute of Medicine (U.S.)., Committee on Pediatric Studies Conducted under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equality Act (PREA)
0
Type: Book
"The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted…
This publication contains a verbatim reproduction of 21 CFR Part 50 Protection of Human Subjects, 21 CFR Part 54 Financial Disclosure by Clinical Investigators, 21 CFR Part 56 Institutional Review Boards and 21 CFR Part 312 Investigational New Drug Application.
(A) This part applies to all clinical investigations regulated by the Food and DrugAdministration under sections 505(i) and 520(g) of the Federal Food, Drug, and CosmeticAct, as well as clinical investigations that support applications for research or marketingpermits for produc…
(A) This part applies to all clinical investigations regulated by the Food and DrugAdministration under sections 505(i) and 520(g) of the Federal Food, Drug, and CosmeticAct, as well as clinical investigations that support applications for research or marketingpermits for produc…
